Limited by computational resources, the Khiabanian lab at Rutgers needed a breakthrough. The lab was looking at rare changes in blood cells linked to a condition called CHIP (clonal hematopoiesis of indeterminate potential). This condition has been associated with certain types of treatment-induced cancers as well as resistance to cancer …